Table 7:
Atrial fibrillation characteristics
| Characteristic | +PAF (n = 43) (%) | Uncomplicated/transient +PAF (n = 28) (%) | Complicated/persistent +PAF (n = 15) (%) |
|---|---|---|---|
| Paroxysmal | 37 (86.0) | 28 (100) | 9 (60.0) |
| Persistent | 6 (14.0) | 0 (0) | 6 (40.0) |
| Cardioversion | 2 (4.7) | 0 (0) | 2 (13.3) |
| Vasopressors | 5 (11.6) | 0 (0) | 5 (33.3) |
| Anticoagulants in hospital | 7 (16.3) | 0 (0) | 7 (46.7) |
| Metoprolol in hospital | 41 (95.3) | 27 (96.4) | 14 (93.3) |
| Amiodarone in hospital | 8 (18.6) | 2 (7.1) | 6 (40.0) |
| Diltiazem in hospital | 2 (4.7) | 0 (0) | 2 (13.3) |
| Digoxin in hospital | 19 (44.2) | 6 (21.4) | 13 (86.7) |
| Anticoagulants on discharge | 4 (9.3) | 0 (0) | 4 (26.7) |
| Metoprolol on discharge | 32 (74.4) | 19 (67.9) | 13 (86.7) |
| Amiodarone on discharge | 2 (4.7) | 0 (0) | 2 (13.3) |
| Diltiazem on discharge | 0 (0) | 0 (0) | 0 (0) |
| Digoxin on discharge | 10 (23.3) | 0 (0) | 10 (66.7) |
| Discharge with PAF | 2 (4.7) | 0 (0) | 2 (13.3) |
| LOS >5 days | 29 (67.4) | 16 (57.1) | 13 (86.7) |
% PAF: postoperative atrial fibrillation; LOS: length of stay.